Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 3.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 53,148 shares of the financial services provider's stock after acquiring an additional 1,828 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd's holdings in CME Group were worth $14,649,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Wayfinding Financial LLC bought a new stake in CME Group during the 1st quarter valued at $25,000. Webster Bank N. A. boosted its position in CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock valued at $25,000 after acquiring an additional 60 shares in the last quarter. Cornerstone Planning Group LLC boosted its position in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 55 shares in the last quarter. Golden State Wealth Management LLC boosted its position in CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 98 shares in the last quarter. Finally, Ransom Advisory Ltd purchased a new stake in shares of CME Group during the 1st quarter valued at $31,000. Institutional investors own 87.75% of the company's stock.
Insider Buying and Selling
In other CME Group news, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the transaction, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. This trade represents a 3.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Sunil Cutinho sold 11,896 shares of CME Group stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider owned 17,440 shares of the company's stock, valued at $4,734,436.80. The trade was a 40.55% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,043 shares of company stock worth $3,527,956. Corporate insiders own 0.30% of the company's stock.
CME Group Stock Performance
NASDAQ CME opened at $260.59 on Friday. The stock has a 50-day simple moving average of $272.25 and a two-hundred day simple moving average of $270.52. The firm has a market capitalization of $93.91 billion, a P/E ratio of 25.23, a PEG ratio of 4.75 and a beta of 0.43. CME Group Inc. has a fifty-two week low of $212.38 and a fifty-two week high of $290.79. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating analysts' consensus estimates of $2.91 by $0.05. The business had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company's revenue was up 10.4% on a year-over-year basis. During the same quarter last year, the business posted $2.56 EPS. On average, equities analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th will be paid a dividend of $1.25 per share. The ex-dividend date is Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group's dividend payout ratio (DPR) is presently 48.40%.
Analyst Upgrades and Downgrades
Several analysts have recently commented on the company. UBS Group decreased their price objective on CME Group from $305.00 to $285.00 and set a "neutral" rating for the company in a report on Monday, September 8th. Erste Group Bank lowered CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Barclays set a $298.00 price objective on CME Group and gave the company an "equal weight" rating in a report on Thursday, July 24th. Citigroup increased their price objective on CME Group from $265.00 to $275.00 and gave the company a "neutral" rating in a report on Thursday, July 3rd. Finally, Wall Street Zen lowered CME Group from a "hold" rating to a "sell" rating in a report on Sunday, July 13th. Four investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have issued a Sell rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Hold" and an average target price of $260.60.
Check Out Our Latest Stock Report on CME
About CME Group
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.